E Dublin
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
- Cancer Genomics and Diagnostics
Papers in ⓘ
- Oncology 6
- Cancer-related Molecular Pathways 5
- HER2/EGFR in Cancer Research 2
- Cutaneous Melanoma Detection and Management 1
- Co-authors
- David A. Levison (4 shared papers)D M Barnes (4 shared papers)Rosemary R. Millis (2 shared papers)C. Fisher (1 shared paper)D.M. MACDONALD (3 shared papers)J.M. McGregor (3 shared papers)C. C.‐W. Yu (2 shared papers)Paul Smith (1 shared paper)
- Journals
- British Journal of Dermatology (3 papers)British Journal of Cancer (2 papers)Human Pathology (1 paper)The Journal of Pathology (1 paper)PubMed (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
E Dublin
8 papers receiving 691 citations
Peers
Comparison fields: 5 of 63
- Oncology 507
- Cancer Research 202
- Immunology and Allergy 60
- Dermatology 85
- Radiology, Nuclear Medicine and Imaging 129
Countries citing papers authored by E Dublin
This map shows the geographic impact of E Dublin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Dublin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Dublin more than expected).
Fields of papers citing papers by E Dublin
This network shows the impact of papers produced by E Dublin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Dublin. The network helps show where E Dublin may publish in the future.
Co-authors
The 24 scholars most cited alongside E Dublin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 204 | |
| 2 | 1992 | 203 | |
| 3 | Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. | 1998 | 97 |
| 4 | 1992 | 87 | |
| 5 | 1993 | 58 | |
| 6 | 2002 | 41 | |
| 7 | 1995 | 20 | |
| 8 | 1999 | 3 |
About E Dublin
E Dublin is a scholar working on Oncology, Immunology and Allergy, Cancer Research, Biotechnology and Dermatology, having authored 8 papers that have together received 713 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), HER2/EGFR in Cancer Research (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Breast Cancer Treatment Studies (1 paper), Cutaneous Melanoma Detection and Management (1 paper), Genetic factors in colorectal cancer (1 paper), Nonmelanoma Skin Cancer Studies (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Oncology (507 citations), Cancer Research (202 citations), Immunology and Allergy (60 citations), Dermatology (85 citations) and Radiology, Nuclear Medicine and Imaging (129 citations). E Dublin has collaborated with scholars based in United Kingdom. Frequent co-authors include David A. Levison, D M Barnes, Rosemary R. Millis, C. Fisher, D.M. MACDONALD, J.M. McGregor, C. C.‐W. Yu, Paul Smith, NR Lemoine and S A Prigent. Their work appears in journals such as British Journal of Dermatology, British Journal of Cancer, Human Pathology, The Journal of Pathology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.